These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11360489)

  • 1. Evaluation of the method for nifedipine administration for a rapid onset of clinical effect: a clinical study in normal volunteers.
    Kubota R; Komiyama T; Shimada H
    Yakugaku Zasshi; 2001 May; 121(5):355-64. PubMed ID: 11360489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?
    Langton PE
    Med J Aust; 1998 Jan; 168(1):43-4. PubMed ID: 9451398
    [No Abstract]   [Full Text] [Related]  

  • 3. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?
    Grossman E; Messerli FH; Grodzicki T; Kowey P
    JAMA; 1996 Oct 23-30; 276(16):1328-31. PubMed ID: 8861992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is sublingual nifedipine administration superior to oral administration in the active treatment of hypertension?
    Diker E; Ertürk S; Akgün G
    Angiology; 1992 Jun; 43(6):477-81. PubMed ID: 1595942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive role of glossopharyngeal nerve stimulation by nifedipine using as calcium channel blocking agent in hypertension: an experimental study.
    Aydin MD; Bayram E; Halici Z; Aydin N; Atalay C; Ulvi H; Kotan D; Gundogdu C
    Arch Pharm Res; 2009 Nov; 32(11):1607-11. PubMed ID: 20091275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.
    Saseen JJ; Carter BL; Brown TE; Elliott WJ; Black HR
    Hypertension; 1996 Jul; 28(1):109-14. PubMed ID: 8675249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine.
    Save T; Shah MU; Ghamande AR; Venkitachalam P
    J Pharm Pharmacol; 1994 Mar; 46(3):192-5. PubMed ID: 8027926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of nifedipine on serum endothelin-1 levels in essential hypertension.
    Akpolat T; Başkol M; Adam B; Arik N; Bedir A
    Clin Nephrol; 1997 Feb; 47(2):130-1. PubMed ID: 9049464
    [No Abstract]   [Full Text] [Related]  

  • 10. "Inappropriate" physician habits in prescribing oral nifedipine capsules in hospitalized patients.
    Rehman F; Mansoor GA; White WB
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):1035-9. PubMed ID: 8896658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antihypertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats.
    Kim YI; Fluckiger L; Hoffman M; Lartaud-Idjouadiene I; Atkinson J; Maincent P
    Br J Pharmacol; 1997 Feb; 120(3):399-404. PubMed ID: 9031742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
    Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
    Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis.
    Gemici K; Baran I; Bakar M; Demircan C; Ozdemir B; Cordan J
    Blood Press; 2003; 12(1):46-8. PubMed ID: 12699135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients.
    Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics and dynamics of nifedipine after oral and sublingual doses.
    McAllister RG
    Am J Med; 1986 Dec; 81(6A):2-5. PubMed ID: 3799661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice.
    Jegasothy R; Paranthaman S
    J Obstet Gynaecol Res; 1996 Feb; 22(1):21-4. PubMed ID: 8624887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual and intravenous ketanserin versus sublingual nifedipine in the treatment of severe hypertension: a randomized study.
    Sechi LA; Tedde R; Cassisa L; Pala A; Orecchioni C; Uneddu F; Melis A
    Clin Ther; 1989; 11(6):834-40. PubMed ID: 2692825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.